BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22098487)

  • 1. The natural history of hepatitis C virus infection acquired during childhood.
    Robinson JL; Doucette K
    Liver Int; 2012 Feb; 32(2):258-70. PubMed ID: 22098487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.
    Posthouwer D; Fischer K; van Erpecum KJ; Mauser-Bunschoten EP
    Transfusion; 2006 Aug; 46(8):1360-6. PubMed ID: 16934072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of hepatitis C virus infection.
    Al-Quaiz MN; Madani TA; Karawi MA
    Saudi Med J; 2003 Jul; 24 Suppl 2():S67-70. PubMed ID: 12897903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C in children: a quaternary referral center perspective.
    Rumbo C; Fawaz RL; Emre SH; Suchy FJ; Kerkar N; Morotti RA; Shneider BL
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):209-16. PubMed ID: 16877987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
    Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C;
    J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of chronic hepatitis C.
    Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
    Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
    Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
    Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b.
    Zein NN; Poterucha JJ; Gross JB; Wiesner RH; Therneau TM; Gossard AA; Wendt NK; Mitchell PS; Germer JJ; Persing DH
    Am J Gastroenterol; 1996 Dec; 91(12):2560-2. PubMed ID: 8946986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.